Brown Advisory Inc Gsk PLC Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$16.13 - $44.61 $238,094 - $658,488	-14,761 Closed	0 $0
Q2 2022 Nov 14, 2022	BUY	$42.05 - $47.77 $59,879 - $68,024	1,424 Added 10.68%	14,761 $643,000
Q2 2022 Sep 13, 2022	SELL	$42.05 - $47.77 $1.23 Million - $1.4 Million	-29,245 Reduced 66.46%	14,761 $643,000
Q2 2022 Aug 02, 2022	BUY	$42.05 - $47.77 $1.29 Million - $1.47 Million	30,669 Added 229.95%	44,006 $1.93 Million
Q1 2022 Nov 14, 2022	SELL	$40.23 - $47.74 $57,287 - $67,981	-1,424 Reduced 9.65%	13,337 $581,000
Q1 2022 Sep 13, 2022	SELL	$40.23 - $47.74 $1.18 Million - $1.4 Million	-29,245 Reduced 68.68%	13,337 $581,000
Q1 2022 May 09, 2022	SELL	$40.23 - $47.74 $7,442 - $8,831	-185 Reduced 0.43%	42,582 $1.87 Million
Q4 2021 Jan 27, 2022	BUY	$38.88 - $45.31 $5,676 - $6,615	146 Added 0.34%	42,767 $1.89 Million
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $323,431 - $359,868	8,338 Added 24.32%	42,621 $1.63 Million
Q2 2021 Jul 29, 2021	SELL	$36.52 - $41.46 $78,554 - $89,180	-2,151 Reduced 5.9%	34,283 $1.37 Million
Q1 2021 May 14, 2021	SELL	$34.27 - $40.01 $33,858 - $39,529	-988 Reduced 2.64%	36,434 $1.3 Million
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $111,477 - $130,683	-3,272 Reduced 8.04%	37,422 $1.38 Million
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $119,246 - $134,515	3,129 Added 8.33%	40,694 $1.53 Million
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $31,015 - $35,692	819 Added 2.23%	37,565 $1.53 Million
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $42,113 - $63,332	-1,297 Reduced 3.41%	36,746 $1.39 Million
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $2,268 - $2,605	-54 Reduced 0.14%	38,043 $1.79 Million
Q3 2019 Nov 14, 2019	BUY	$40.46 - $43.52 $19,258 - $20,715	476 Added 1.27%	38,097 $1.63 Million
Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $46,137 - $50,001	-1,171 Reduced 3.02%	37,621 $1.51 Million
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $58,549 - $64,803	-1,518 Reduced 3.77%	38,792 $1.62 Million
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $115,516 - $130,460	-3,056 Reduced 7.05%	40,310 $1.54 Million
Q3 2018 Nov 13, 2018	BUY	$39.75 - $42.69 $132,566 - $142,371	3,335 Added 8.33%	43,366 $1.74 Million
Q2 2018 Aug 10, 2018	SELL	$39.61 - $42.76 $45,036 - $48,618	-1,137 Reduced 2.76%	40,031 $1.61 Million
Q1 2018 Jun 28, 2018	BUY	$36.18 - $40.15 $97,830 - $108,565	2,704 Added 7.03%	41,168 $1.61 Million
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $1.93 Million - $2.14 Million	-53,299 Reduced 58.08%	38,464 $1.5 Million
Q4 2017 Feb 12, 2018	SELL	$35.34 - $41.9 $763,167 - $904,830	-21,595 Reduced 19.05%	91,763 $3.26 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $596,214 - $628,111	15,117 Added 15.39%	113,358 $4.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	98,241	98,241 $4.24 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account